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Abstract
Tracing risk factors for acquiring hepatitis C virus (HCV) in an
HCV-infected patient, the only identiﬁed risk was working at the
same butcher’s counter of a supermarket as another HCV-
infected patient, using a common ham cutting machine, with fre-
quent bleeding hand injuries. A phylogenetic analysis showed a
high percentage of nucleotide homology between the two
patients’ strains.
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In developed countries, hepatitis C virus (HCV) is mainly
transmitted through parenteral exposure, including drug use
by injection and unsafe invasive therapeutic or nontherapeu-
tic practices, blood transfusions before 1991 and occupa-
tional exposure among healthcare workers [1,2]. We report
a case of likely HCV transmission between two women
working at the same meat counter of a supermarket.
Ms Z and Ms C, both infected with chronic HCV, were
followed in the hepato-gastroenterology unit of the Tourco-
ing Hospital, in France.
Ms Z (Patient 1), a 40 year-old woman, was diagnosed
with HCV in September 2003. She reported a history of
intravenous drug use in 1983. She was clinically asymptom-
atic and had normal transaminase levels at her ﬁrst visit. A
HCV-RNA test showed HCV genotype 1a with an estimated
viral load of 5.67 log10 UI/mL. By June 2004, her transami-
nase levels had increased. Serum ﬁbrosis markers showed a
stage F1 liver ﬁbrosis. She initiated treatment (peg-Inter-
feron-Ribavirin), but stopped in October 2004 because of
virological failure.
Ms C (Patient 2), a 44 year-old woman with no known
risk factors for HCV, was diagnosed with HCV in September
2005. She was screened for HCV because of observed ast-
haenia with elevated transaminase levels. An HCV-RNA test
showed HCV genotype 1a with an estimated viral load of
5.23 log10 UI/mL.
When asked for risk factors, Ms C revealed that she had
worked at the same supermarket meat counter as Ms Z
since 1988, using the same meat-slicing machine. The spiked
trays of the meat slicers can quite easily cause haemorrhages
in the hands of its users. Indeed, Ms C said that she and Ms
Z frequently sustained hand injuries and did not always wear
gloves. The two patients had no contact with each other
outside of work.
HCV genotype was determined through direct sequencing
of the 5¢ noncoding region of the HCV genome, using the
TRUGENEHCV 5’NC Genotyping Kit (Siemens Bayer,
Siemens Healthcare Diagnostics, Bayswater, Australia). We
found the same HCV genotype for both patients (1a). Samples
were sent to the French National Reference Center for Viral
Hepatitis B, C, and Delta (Henri Mondor Hospital, Creteil).
To analyze the genetic and phylogenetic relationship between
the HCV strains isolated from the two patients, the three
HCV genomic regions were PCR-ampliﬁed and sequenced: a
portion of the nonstructural 5B (NS5B) coding region, 286 bp
in length (nucleotide positions 8325–8610 according to strain
HCV-H, accession number M67463); the region coding for
the full-length E1 envelope glycoprotein, 551 bp in length; and
the region coding for hypervariable region 1 (HVR1) of the
E2 envelope glycoprotein, 81 bp in length.
Determination of the HCV genotype was performed by
means of a phylogenetic analysis of NS5B sequences, which
included prototype sequences from various subtypes of HCV
genotypes 1–6 [3]. Genetic relatedness of HCV strains was
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assessed by means of phylogenetic analyses of the three
NS5B, E1 and HVR1 regions. Sequence alignments were
performed by means of CLUSTAL W [4]. Phylogenetic relation-
ships were deduced by means of DNADIST-NEIGHBOR, in
PHYLIP, version 3.5 [5]. For Neighbour-joining analysis, a Kim-
ura two-parameter distance matrix with a transition/trans-
version ratio (Ts/Tv) of 2.0 was used. Trees were drawn
with NJ-PLOT software [6]. Their robustness was assessed by
bootstrap analysis of 1000 replicates by means of the SEQ-
BOOT in PHYLIP.
Phylogenetic analyses of these two samples conﬁrmed
their similarity: 95% of the nucleotides were identical in the
NS5B and in the E1 regions, and 81% were identical in the
HVR1 region. When we aligned the sequences from the E1
region of the two patients’ HCV strains with the E1 region
of 52 other sequences found in the French National Refer-
ence Center for Viral Hepatitis B, C and Delta laboratory,
the strains appeared to be much closer to each other (95%)
than to any of the others included: the mean identity with
the other strains for the E1 region of the strain from patient
1 was 92.5% (range 88–95.1%) and, for the E1 region of the
strain from patient 2, the mean identity was 92.1% (range
88–94%). The same results were observed for HVR1 region:
81% identity between the two patients’ strains sequences in
this region vs. 69% (range 50.6–75.3%) and 66.2% (range
51.8–75.3%) between the strains from patient 1 and patient
2 and 15 other laboratory HVR1 strain sequences, respec-
tively (Figs 1 and 2).
These identity levels between the two patients’ strains are
very high in comparison with the previously published data.
Sequence variability within genotype has been described in
several studies. Rates of HCV sequence changes were found
to be 1.44 · 10)3 nucleotide changes per site per year over
the whole genome, or 4.1 and 7.1 · 10)4 changes per site
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FIG. 1. Phylogenetic tree for the NS5B
sequences (nucleotide positions 8325–
8610) of the two patients in whom hep-
atitis C virus (HCV) transmission was
suspected (patients 1 and 2, in bold),
along with reference HCV strains of dif-
ferent genotypes and subtypes (the type
and subtype are indicated before the
strain identiﬁcation letters and/or num-
bers). The nucleotide sequence of the
NS5B gene of HCV strain EHK2 was
used as an outgroup root.
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per year in the NS5 and E1 region, respectively [7]. More-
over, in HVR1 of E2, the variability is much greater, as
shown in an inter- and intra-individuals study of HVR1 evolu-
tionary quasi-species analysis [8].
Phylogenetic analyses of both patients’ HCV strains
strongly suggest virus transmission from one to the other
through occupational contamination. Ms C’s medical history
and as lack of other risk factors for HCV also act as strong
arguments for this method of transmission.
This observation, reporting an unsuspected method of
HCV transmission, is relevant in the actual context of HCV
epidemiology. The prevalence of chronic carriers of HCV is
not negligible. In France, it was recently estimated that
232 196 individuals (i.e. a prevalence of 0.53%) are chroni-
cally infected with HCV (i.e. HCV-RNA positive) [9]. No risk
factors are identiﬁed in a high proportion of chronic careers
of HCV. In Italy and France, the proportion of recently diag-
nosed patients with HCV infections without HCV infection
risk factors has been estimated at 13–25% [10,11]. This
unsuspected method of transmission could explain the lack
of reported risk-factors for HCV infection among some
infected patients.
Occupational transmission of HCV has been reported in
the past but mainly among healthcare workers after needle-
stick injuries [2,12,13], with an average rate of HCV infec-
tion of 0.5% [14]. In a study on exposure to blood among
paramedics, subjects were found to be at highest risk of
exposure during contact to non-intact skin, which was
more frequent than needlestick and mucocutaneous expo-
sures [15]. Very little information is available on occupa-
tional transmission of HCV in non-healthcare settings. This
observation emphasizes the fact that the promotion of
1a_BS6C1
1a_RDPRESC1C2
1a_AVV4C7
1a_SDPRESC1C11
1a_RCPRESC1C2
1a_SAPRESC2C12
1a_DJ6-4
1a_12v10c16
1a_SEPRESC1C2
1a_HCV-TWB-1
1a_HEC278830
1a_1A14-1
1a_HPCSTRUCTA
1a_59B
1a_C107-91 
1a_GLASGOW 
1a_FM-78 
1a_S6a
1a_HW-81
1a_H77C
1a_HCV-H
1a_COLONEL
1a_SGPRESC2D
1a_RBPRESC1C4
1a_DO56-E1-2
1a_JL-77
1a_LIV23
1a_LTD6-2-XF224
1a_HCV-1/79
1a_PHCV-1/SF9-A
1a_HCV-PT
1a_SP2
1a_REPRESC1C2
1a_CF-83
1a_G42C1
1a_RAPRESC1C2
1a_SBPRESC2C1
1a_SFPRESC1D
1a_BES3C6
1a_SCPRESC1C6
1a_PD102
Patient 2
Patient 1
1b_HCV-N
2b_JFH-1
3a_CB 
5a_SA13
4a_ED43 
6a_6a33 
0.05
90 
49 
FIG. 2. Phylogenetic tree plotted with
E1 envelope glycoprotein sequences
from the two patients in whom an hepa-
titis C virus (HCV) transmission in a
working context was suspected
(patients 1 and 2, in bold) and with ref-
erence HCV strains of different geno-
types and subtypes (the type and
subtype are indicated before the strain
identiﬁcation letter and/or numbers).
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information on hepatitis C and other bloodborne viruses is
also needed in non-healthcare settings, particularly in prac-
tices where sharp instruments such as slicers that are likely
to cause hand injuries are used and shared by workers. In
these practices, healthcare authorities should highlight the
importance of wearing gloves and the prevention of cutting
injuries.
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Direct pathogen detection from swab
samples using a new high-throughput
sequencing technology
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Abstract
The detection of emerging infectious diseases has been a contin-
uing concern, especially with the novel inﬂuenza A (H1N1) viral
pandemic of 2009. In the present study, we validated a ‘second-
generation’ parallel sequencing platform for viral detection in
swab samples collected during recent inﬂuenza virus infections
in Beijing. This operation yielded millions of valid reads per sam-
ple and resulted in an almost complete spectrum of nucleotide
information. Importantly, novel A (H1N1) and seasonal A
(H3N2) inﬂuenza virus-derived sequences were detected with-
out prior knowledge or use of genetic information in advance,
suggesting that this approach could be a valuable tool for diag-
nosing emerging infectious diseases.
Keywords: Emerging infectious diseases, high-throughput
sequencing technology, novel inﬂuenza A (H1N1) virus,
Solexa system, viral detection
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